Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02782130 · ClinicalTrials.gov registry record · NA
Epic Allies HIV ART Adherence Intervention
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 146
- Enrollment target
NCT02782130 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 146 participants.
The verdict
NCT02782130, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 146 participants
- Enrollment target
Study Summary
This is a two-arm, randomized-controlled trial (RCT) that will test the acceptability, impact, and long-term sustainability of the Epic Allies intervention application (app), a theory-based mobile app that utilizes game mechanics and social networking features to improve engagement in care, antiretroviral therapy (ART) uptake, ART adherence, and viral suppression among HIV-positive young men who have sex with men (YMSM) and trans women who have sex with men. Subjects will be randomized to either the intervention branch of the Epic Allies app or the control branch of the app.
Interventions
- BEHAVIORAL Epic Allies App Intervention
- BEHAVIORAL Epic Allies - Control Branch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2015-06 |
| Est. Completion | 2017-12-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02782130
The ClinicalTrials.gov registry entry for NCT02782130 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Epic Allies App Intervention is the first listed.
NCT02782130 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02782130 about?
NCT02782130 is a clinical study titled "Epic Allies HIV ART Adherence Intervention". This is a two-arm, randomized-controlled trial (RCT) that will test the acceptability, impact, and long-term sustainability of the Epic Allies intervention application (app), a theory-based mobile app that utilizes game mechanics and social networking features to improve engagement in care, antiretr...
What is the current status of trial NCT02782130?
This trial is currently completed. It is a NA study. The enrollment target is 146 participants. The study started on 2015-06. Estimated completion is 2017-12-14.
What interventions are being tested in trial NCT02782130?
The interventions under investigation include: Epic Allies App Intervention (BEHAVIORAL), Epic Allies - Control Branch (BEHAVIORAL).
Who is sponsoring clinical trial NCT02782130?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.